Sundermeyer, Jonas
Schock, Alina
Kellner, Caroline
Haller, Paul M.
Lehmacher, Jonas
Thießen, Niklas
Toprak, Betül
Scharlemann, Lea
Twerenbold, Raphael
Sörensen, Nils Arne
Clemmensen, Peter
Neumann, Johannes T. http://orcid.org/0000-0002-9478-2757
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 2 May 2024
Accepted: 25 July 2024
First Online: 5 August 2024
Declarations
:
: JS received travel grants from Abiomed, outside of the submitted work. PMH is funded by grants of the German Foundation for Heart Research, and the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)–10086/1-1). BT receives project-related funding by the German Foundation of Heart Research, Ernst und Berta Grimmke-Stiftung (co-recipient) and Werner Otto Stiftung outside the submitted work. BT also received travel grants by the German Center for Cardiovascular Research (DZHK) and is the representative of the partner sites Hamburg/Kiel/Lübeck in the Use and Access Committee of the DZHK Heart Bank. PC has previously or currently been involved in research contracts, consulting, speakers bureau or received research and educational grants from: Abbott, AstraZeneca, Aventis, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Eli-Lilly, Evolva, Fibrex, Idorsia, Janssen, Merck, Myogen, Medtronic, Mitsubishi Pharma, The Medicines Company, Nycomed, Organon, Pfizer, Pharmacia, Philips, Regado, Sanofi, Searle, Servier, ViFor Pharma. JTN has received speaker honoraria/consulting honoraria from Abbott, PHC, Roche, and Siemens. JTN, and RT are listed as co-inventors of an international patent on the use of a computing device to estimate the probability of myocardial infarction (International Publication Number WO/2022/043229A1), as well as co-founders and shareholders of the ARTEMIS Hamburg GmbH. RT reports research support from the German Center for Cardiovascular Research (DZHK), the Kühne Foundation, the Joachim Herz Foundation, the Swiss National Science Foundation (Grant No P300PB_167803) and the Swiss Heart Foundation as well as speaker honoraria/consulting honoraria from Abbott, Amgen, Astra Zeneca, Psyros, Roche, Siemens, Singulex and Thermo Scientific BRAHMS. All other authors reported no conflict of interest.